13F-HR/A filed by Boxer Capital Management, LLC
Boxer Capital Management, LLC filed this 13F-HR/A for the quarter ended 2025-03-31, filed 2026-02-17, with 28 holding rows worth $332,470,540.
- Accession
- 0002018299-26-000003
- Filer
- CIK 2018299
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, amendment of type restatement, 28 entries on the cover page, a total value of $332,470,540 stated on the cover page (in dollars after the unit check, H1), rows summing to $332,470,540 with VALUE read as dollars as filed, 13F file number 028-25329. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,317,977 | $46,603,667 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 450,000 | $31,914,000 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 700,000 | $29,463,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 865,000 | $25,534,800 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 1,300,000 | $24,167,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 600,000 | $20,130,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,796,341 | $17,514,325 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 713,000 | $15,593,310 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,810,000 | $15,403,100 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 10,380,999 | $14,221,969 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 671,358 | $13,212,325 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,732,571 | $9,667,746 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,189,943 | $9,436,248 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 325,000 | $8,895,250 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 690,000 | $8,538,750 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 750,000 | $7,950,000 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 200,000 | $6,786,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 563,067 | $6,689,236 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,750,000 | $6,195,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 1,240,700 | $4,590,590 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 250,000 | $3,400,000 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,035,000 | $2,908,350 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 2,108,014 | $1,623,171 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 80,125 | $1,390,970 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 250,000 | $377,500 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 145,000 | $176,900 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 266,666 | $85,333 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 66,666 | $2,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002018299-25-000002 | superseded | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0002018299-26-000003 | this filing | 2026-02-17 | acceptance time not in the bulk data set |